Sudden Conjunctivitis, Lymphopenia, and Rash Combined With Hemodynamic Changes (SCoRCH) After Trimethoprim-Sulfamethoxazole Use: A Case Series Study of a Hypersensitivity Reaction.
Sign Up to like & getrecommendations! Published in 2022 at "JAMA dermatology"
DOI: 10.1001/jamadermatol.2022.4657
Abstract: Importance Trimethoprim-sulfamethoxazole (TMP-SMX) hypersensitivity reaction, ranging from circulatory shock to aseptic meningitis and respiratory failure, is a potentially life-threatening condition with dermatologic relevance. Objective To describe the mucocutaneous findings and clinical features of TMP-SMX hypersensitivity… read more here.
Keywords: conjunctivitis; hemodynamic changes; tmp smx; reaction ... See more keywords
Safety of the concomitant use of methotrexate and a prophylactic dose of trimethoprim-sulfamethoxazole
Sign Up to like & getrecommendations! Published in 2018 at "Clinical Rheumatology"
DOI: 10.1007/s10067-018-4005-6
Abstract: The objective of this study was to investigate risk factors for cytopenia when a prophylactic dose of trimethoprim-sulfamethoxazole (TMP-SMX) was co-administered with methotrexate (MTX). Patients who received MTX with or without a prophylactic dose of… read more here.
Keywords: dose; dose tmp; prophylactic dose; tmp smx ... See more keywords
Apparently trivial but serious mistakes: the underestimated risk of a QT prolongation
Sign Up to like & getrecommendations! Published in 2018 at "Aging Clinical and Experimental Research"
DOI: 10.1007/s40520-018-0900-6
Abstract: Polypharmacy is very common among older adults and is often associated with adverse drug events and potentially severe drug–drug interactions (DDIs) [1]. Although most DDIs might be prevented or avoided, their lack of recognition is… read more here.
Keywords: drug; day; prolongation; tmp smx ... See more keywords
Trimethoprim-sulfamethoxazole vs. colistin or ampicillin-sulbactam for the treatment of carbapenem-resistant Acinetobacter baumannii: A retrospective matched cohort study.
Sign Up to like & getrecommendations! Published in 2019 at "Journal of global antimicrobial resistance"
DOI: 10.1016/j.jgar.2018.12.001
Abstract: OBJECTIVES This study aimed to assess the effectiveness of trimethoprim-sulfamethoxazole (TMP/SMX) as monotherapy for the treatment of carbapenem-resistant Acinobacter baumannii (A. baumannii) (CRAB) infections. METHODS This retrospective cohort study included patients receiving TMP/SMX as the… read more here.
Keywords: treatment carbapenem; treatment; trimethoprim sulfamethoxazole; tmp smx ... See more keywords
Resistance among urinary tract pathogens collected in Europe during 2018.
Sign Up to like & getrecommendations! Published in 2020 at "Journal of global antimicrobial resistance"
DOI: 10.1016/j.jgar.2020.10.020
Abstract: OBJECTIVES Escherichia coli, Klebsiella pneumoniae and Proteus mirabilis are urinary tract infection (UTI) pathogens and extended spectrum β-lactamase (ESBL)-producing pathogens exhibit co-resistance to oral fluoroquinolones (FQ) and trimethoprim-sulfamethoxazole (TMP-SMX). This study assessed the prevalence of… read more here.
Keywords: urinary tract; esbl phenotypes; resistance among; resistance ... See more keywords
Impact of Allergy and Resistance on Antibiotic Selection for Recurrent Urinary Tract Infections in Older Women.
Sign Up to like & getrecommendations! Published in 2018 at "Urology"
DOI: 10.1016/j.urology.2017.08.070
Abstract: OBJECTIVES To review the impact of antibiotic allergy and resistance in older women with recurrent urinary tract infections (RUTIs) as determinants for a suitable oral antibiotic treatment choice. METHODS A prospectively maintained database of women… read more here.
Keywords: allergy resistance; resistance; older women; allergic resistant ... See more keywords
Patient and treatment pathways for toxoplasmosis in the United States: data analysis of the Vizient Health Systems Data from 2011 to 2017
Sign Up to like & getrecommendations! Published in 2018 at "Pathogens and Global Health"
DOI: 10.1080/20477724.2018.1552644
Abstract: ABSTRACT Toxoplasmosis causes substantial morbidity and mortality in the United States (US). Clinical manifestations to toxoplasmosis vary and there is limited information on incidence or treatment patterns in the US. Treatment pathways for pyrimethamine-based regimens… read more here.
Keywords: treatment; toxoplasmosis; based regimens; tmp smx ... See more keywords
Low-Dose TMP-SMX in the Treatment of Pneumocystis jirovecii Pneumonia: A Systematic Review and Meta-analysis
Sign Up to like & getrecommendations! Published in 2020 at "Open Forum Infectious Diseases"
DOI: 10.1093/ofid/ofaa112
Abstract: Abstract Background Pneumocystis jirovecii pneumonia (PJP) remains a common and highly morbid infection for immunocompromised patients. Trimethoprim-sulfamethoxazole (TMP-SMX) is the antimicrobial treatment of choice. However, treatment with TMP-SMX can lead to significant dose-dependent renal and… read more here.
Keywords: pjp; pneumocystis jirovecii; treatment; review ... See more keywords
Trimethoprim-Sulfamethoxazole Versus Levofloxacin for Stenotrophomonas maltophilia Infections: A Retrospective Comparative Effectiveness Study of Electronic Health Records from 154 US Hospitals
Sign Up to like & getrecommendations! Published in 2022 at "Open Forum Infectious Diseases"
DOI: 10.1093/ofid/ofab644
Abstract: Abstract Background Trimethoprim-sulfamethoxazole (TMP-SMX) is considered first-line therapy for Stenotrophomonas maltophilia infections based on observational data from small studies. Levofloxacin has emerged as a popular alternative due to tolerability concerns related to TMP-SMX. Data comparing… read more here.
Keywords: maltophilia infections; tmp smx; levofloxacin; smx ... See more keywords
1578. Back to Bactrim–Utilizing Preferred Prophylaxis Strategies in Immunocompromised Hosts Via a Trimethoprim-Sulfamethoxazole Rechallenge Program
Sign Up to like & getrecommendations! Published in 2018 at "Open Forum Infectious Diseases"
DOI: 10.1093/ofid/ofy210.1406
Abstract: Abstract Background Trimethoprim sulfamethoxazole (TMP-SMX) is the preferred agent for Pneumocystis jirovecii pneumonia prophylaxis in immunocompromised hosts (ICH). However, TMP-SMX is frequently avoided due to an adverse drug reaction (ADR) history. We report on a… read more here.
Keywords: smx adr; immunocompromised hosts; smx; trimethoprim sulfamethoxazole ... See more keywords
1592. Safety of Oral Trimethoprim/Sulfamethoxazole Prophylaxis in Renal Transplant Recipients
Sign Up to like & getrecommendations! Published in 2018 at "Open Forum Infectious Diseases"
DOI: 10.1093/ofid/ofy210.1420
Abstract: Abstract Background Trimethoprim/sulfamethoxazole (TMP/SMX) is the agent of choice for Pneumocystis jirovecii Pneumonia (PJP) prophylaxis in renal transplant (RT) recipients. All other prophylactic agents are considered second-line due to efficacy, drug intolerances, cost, administration requirements,… read more here.
Keywords: trimethoprim sulfamethoxazole; prophylaxis renal; smx; tmp smx ... See more keywords